Erratum to "Novel analogs of d-e-MAPP and B13. Part 1: Synthesis and evaluation as potential anticancer agents" [Bioorg. Med. Chem. 16 (2008) 1015-1031] (DOI:10.1016/j.bmc.2007.08.033);Novel analogs of d-e-MAPP and B13. Part 1: Synthesis and evaluation as potential anticancer agents

Bioorganic and Medicinal Chemistry

Volumn 16, Issue 2, 2008, Pages 1015-1031

  Szulc, Zdzislaw M ^a   Mayroo, Nalini ^a   Bai, AiPing ^a   Bielawski, Jacek ^a   Liu, Xiang ^a   Norris, James S ^a   Hannun, Yusuf A ^a   Bielawska, Alicja ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

B13; Ceramidase; Ceramidase inhibitors; Ceramide; Cytotoxicity; d e MAPP; LC MS; Lysosomotropic; Mitochondriotropic; NMR; Synthesis

Indexed keywords

ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; LCL 120; LCL 204; LCL 284; LCL 385; LCL 85; N MYRISTOYLAMINO 4' NITRO PHENYLPROPANDIOL 1,3; N MYRISTOYLAMINO PHENYLPROPANOL 1; UNCLASSIFIED DRUG; UREA DERIVATIVE;

ANALYTIC METHOD; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG DESIGN; DRUG POTENCY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; PHYSICAL CHEMISTRY;

EID: 38549176296     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2008.03.001     Document Type: Erratum

References (56)

1. Adjei A.A., and Rowinsky E.K. Cancer Biol. Ther. 2 (2003) S5
2. Bagnato J.D., Eilers A.L., Horton R.A., and Grissom C.B. J. Org. Chem. 69 (2004) 8987
3. Kamb A., Wee S., and Lengauer C. Nat. Rev. Drug Discov. 6 (2007) 115
4. Pettus B.J., Chalfant C.E., and Hannun Y.A. Biochim. Biophys. Acta 1585 (2002) 114
5. Maceyka M., Payne S.G., Milstien S., and Spiegel S. Biochim. Biophys. Acta 1585 (2002) 193
6. Taha T.A., Mullen T.D., and Obeid L.M. Biochim. Biophys. Acta 1758 (2006) 2027
7. Ogretmen B., and Hannun Y.A. Nat. Rev. Cancer 4 (2004) 604
8. Reynolds C.P., Maurer B.J., and Kolesnick R.N. Cancer Lett. 206 (2004) 169
9. Fillet M., Bentires-Alj M., Deregowski V., Greimers R., Gielen J., Piette J., Bours V., and Merville M.P. Biochem. Pharmacol. 65 (2003) 1633
10. Lopez-Marure R., Gutierrez G., Mendoza C., Ventura J.L., Sanchez L., Reyes Maldonado E., Zentella A., and Montano L.F. Biochem. Biophys. Res. Commun. 293 (2002) 1028
11. Ogretmen B., Pettus B.J., Rossi M.J., Wood R., Usta J., Szulc Z., Bielawska A., Obeid L.M., and Hannun Y.A. J. Biol. Chem. 277 (2002) 12960
12. Shabbits J.A., and Mayer L.D. Biochim. Biophys. Acta 1612 (2003) 98
13. Stover T., and Kester M.J. Pharmacol. Exp. Ther. 307 (2003) 468
14. Dindo D., Dahm F., Szulc Z., Bielawska A., Obeid L.M., Hannun Y.A., Graf R., and Clavien P.A. Mol. Cancer Ther. 5 (2006) 1520
15. Rossi M.J., Sundararaj K., Koybasi S., Phillips M.S., Szulc Z.M., Bielawska A., Day T.A., Obeid L.M., Hannun Y.A., and Ogretmen B. Otolaryngol. Head Neck Surg. 132 (2005) 55
16. Senkal C.E., Ponnusamy S., Rossi M.J., Sundararaj K., Szulc Z., Bielawski J., Bielawska A., Meyer M., Cobanoglu B., Koybasi S., Sinha D., Day T.A., Obeid L.M., Hannun Y.A., and Ogretmen B.J. Pharmacol. Exp. Ther. 317 (2006) 1188
17. Szulc Z.M., Bielawski J., Gracz H., Gustilo M., Mayroo N., Hannun Y.A., Obeid L.M., and Bielawska A. Bioorg. Med. Chem. 14 (2006) 7083
18. Abe A., Radin N.S., Shayman J.A., Wotring L.L., Zipkin R.E., Sivakumar R., Ruggieri J.M., Carson K.G., and Ganem B. J. Lipid Res. 36 (1995) 611
19. Bedia C., Triola G., Casas J., Llebaria A., and Fabrias G. Org. Biomol. Chem. 3 (2005) 3707
20. Bielawska A., Greenberg M.S., Perry D., Jayadev S., Shayman J.A., McKay C., and Hannun Y.A. J. Biol. Chem. 271 (1996) 12646
21. Bielawska A., Linardic C.M., and Hannun Y.A. J. Biol. Chem. 267 (1992) 18493
22. Dagan A., Wang C., Fibach E., and Gatt S. Biochim. Biophys. Acta 1633 (2003) 161
23. Gouaze V., Liu Y.Y., Prickett C.S., Yu J.Y., Giuliano A.E., and Cabot M.C. Cancer Res. 65 (2005) 3861
24. Granot T., Milhas D., Carpentier S., Dagan A., Segui B., Gatt S., and Levade T. Leukemia 20 (2006) 392
25. Grijalvo S., Bedia C., Triola G., Casas J., Llebaria A., Teixido J., Rabal O., Levade T., Delgado A., and Fabrias G. Chem. Phys. Lipids 144 (2006) 69
26. He X., Dagan A., Gatt S., and Schuchman E.H. Anal. Biochem. 340 (2005) 113
27. Holman D.H., Turner L.S., El-Zawahry A., Elojeimy S., Liu X., Bielawski J., Szulc Z.M., Norris K., Zeidan Y.H., Hannun Y.A., Bielawska A., and Norris J.S. Cancer Chemother. Pharmacol. (2007)
28. Liu X., Elojeimy S., El-Zawahry A.M., Holman D.H., Bielawska A., Bielawski J., Rubinchik S., Guo G.W., Dong J.Y., Keane T., Hannun Y.A., Tavassoli M., and Norris J.S. Mol. Ther. 14 (2006) 637
29. Morales A., Paris R., Villanueva A., Llacuna L., Garcia-Ruiz C., and Fernandez-Checa J.C. Oncogene 26 (2007) 905
30. Norris J.S., Bielawska A., Day T., El-Zawahri A., ElOjeimy S., Hannun Y., Holman D., Hyer M., Landon C., Lowe S., Dong J.Y., McKillop J., Norris K., Obeid L., Rubinchik S., Tavassoli M., Tomlinson S., Voelkel-Johnson C., and Liu X. Cancer Gene Ther. 13 (2006) 1045
31. Norris J.S., Norris K.L., Holman D.H., El-Zawahry A., Keane T.E., Dong J.Y., and Tavassoli M. Future Oncol. 1 (2005) 115
32. Raisova M., Goltz G., Bektas M., Bielawska A., Riebeling C., Hossini A.M., Eberle J., Hannun Y.A., Orfanos C.E., and Geilen C.C. FEBS Lett. 516 (2002) 47
33. Samsel L., Zaidel G., Drumgoole H.M., Jelovac D., Drachenberg C., Rhee J.G., Brodie A.M., Bielawska A., and Smyth M.J. Prostate 58 (2004) 382
34. Selzner M., Bielawska A., Morse M.A., Rudiger H.A., Sindram D., Hannun Y.A., and Clavien P.A. Cancer Res. 61 (2001) 1233
35. Alphonse G., Bionda C., Aloy M.T., Ardail D., Rousson R., and Rodriguez-Lafrasse C. Oncogene 23 (2004) 2703
36. Auge N., Nikolova-Karakashian M., Carpentier S., Parthasarathy S., Negre-Salvayre A., Salvayre R., Merrill Jr. A.H., and Levade T.J. Biol. Chem. 274 (1999) 21533
37. Lepine S., Lakatos B., Courageot M.P., Le Stunff H., Sulpice J.C., and Giraud F. J. Immunol. 173 (2004) 3783
38. Maupas-Schwalm F., Auge N., Robinet C., Cambus J.P., Parsons S.J., Salvayre R., and Negre-Salvayre A. FASEB J. 18 (2004) 1398
39. Payne S.G., Brindley D.N., and Guilbert L.J. J. Cell Physiol. 180 (1999) 263
40. Rodriguez-Lafrasse C., Alphonse G., Aloy M.T., Ardail D., Gerard J.P., Louisot P., and Rousson R. Int. J. Cancer 101 (2002) 589
41. Kobayashi S., Matsubara R., Nakamura Y., Kitagawa H., and Sugiura M. J. Am. Chem. Soc. 125 (2003) 2507
42. Usta J., El Bawab S., Roddy P., Szulc Z.M., Hannun Y.A., and Bielawska A. Biochemistry 40 (2001) 9657
43. Dubowchik G.M., Padilla L., Edinger K., and Firestone R.A. J. Org. Chem. 61 (1996) 4676
44. Firestone R.A., Pisano J.M., and Bonney R.J. J. Med. Chem. 22 (1979) 1130
45. Kaufmann A.M., and Krise J.P. J. Pharm. Sci. 96 (2007) 729
46. Niemann A., Baltes J., and Elsasser H.P. J. Histochem. Cytochem. 49 (2001) 177
47. Babia T., Ledesma M.D., Saffrich R., Kok J.W., Dotti C.G., and Egea G. Traffic 2 (2001) 395
48. Hu W., Xu R., Zhang G., Jin J., Szulc Z.M., Bielawski J., Hannun Y.A., Obeid L.M., and Mao C. Mol. Biol. Cell 16 (2005) 1555
49. Lim S., Ryu J.H., Im C., and Yim C.B. Arch. Pharm. Res. 26 (2003) 270
50. Alley M.C., Scudiero D.A., Monks A., Hursey M.L., Czerwinski M.J., Fine D.L., Abbott B.J., Mayo J.G., Shoemaker R.H., and Boyd M.R. Cancer Res. 48 (1988) 589
51. Boyd M.R., and Paull K.D. Drug Dev. Res. 34 (1995) 91
52. Kuo J.S., Lin N.N., Cheng W.Y., Cheng F.C., and Chai C.Y. Chin. J. Physiol. 36 (1993) 101
53. Leteurtre F., Kohlhagen G., Paull K.D., and Pommier Y. J. Natl. Cancer Inst. 86 (1994) 1239
54. Monks A., Scudiero D., Skehan P., Shoemaker R., Paull K., Vistica D., Hose C., Langley J., Cronise P., Vaigro-Wolff A., et al. Natl. Cancer Inst. 83 (1991) 757
55. Bielawski J., Szulc Z.M., Hannun Y.A., and Bielawska A. Methods 39 (2006) 82
56. Bielawska A., Bielawski J., Szulc Z.M., Mayroo N., Liu X., Bai A., Elojeimy S., Norris J., and Hannun Y.A. Bioorg. Med. Chem. 16 (2008) 1032